TABLE.
Patient no. | No. of paths | Fluorescence along paths | Intraop diagnosis | Final diagnosis | 0 mm fluorescence | 0 mm diagnosis |
---|---|---|---|---|---|---|
1 | 1 (+1) | Pos | ND | Glioblastoma | Pos | HGT |
2 | 2 | Pos | – | Glioblastoma | Pos | HGT |
Pos | D | Neg | Gliosis + TC | |||
3 | 1 | Pos | D | Glioblastoma | Pos | HGT |
4 | 1 | Pos | D | Glioblastoma | Pos | Gliosis + TC |
5 | 1 | Pos | D | Glioblastoma | Pos | HGT |
6 | 2 | Neg | – | Glioblastoma | Neg | |
Pos | D | Pos | HGT | |||
7 | 1 | Pos | D | Glioblastoma | Pos | HGT |
8 | 2 | Pos | ND | Glioblastoma | Neg | HGT |
Pos | – | Pos | HGT | |||
9 | 3 | NM | D | Lymphoma | No signal | HGT |
Pos | – | Neg | HGT | |||
Pos | – | Pos | HGT | |||
10 | 1 | Pos | ND | Glioblastoma | Pos | HGT |
11 | 1 | Pos | D | Glioblastoma | Neg | Necrosis |
12 | 1 | Pos | D | Lymphoma | Pos | Gliosis + TC |
13 | 1 | Pos | D | Glioblastoma | Pos | HGT |
14 | 1 | Pos | D | Glioblastoma | Pos | HGT |
15 | 2 | NM | D | Glioblastoma | No signal | HGT |
Pos | – | Pos | HGT | |||
16 | 1 | Pos | D | Glioblastoma | Pos | HGT |
17 | 1 | Pos | D | Glioblastoma | Pos | HGT |
18 | 3 | Neg | – | Glioblastoma | Neg | – |
Neg | – | Neg | – | |||
Pos | D | Pos | HGT | |||
19 | 1 | Pos | D | Astrocytoma | Pos | HGT |
20 | 1 | Pos | D | Glioblastoma | Pos | HGT |
ND: nondiagnostic; D: diagnostic; Pos: positive; Neg: negative; TC: tumor cell; HGT: high-grade tumor; NM: not measurable. Dash (–) is assigned to trajectories where no biopsies were taken.